Korean trials. If results prove Oviplex 97% better than the traditional CA125 ovarian cancer diagnostic blood tests then HTX is in. Results expected out around June 2011.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game